

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 7.48290684 |
| 2 | translational termination (GO:0006415) | 7.08163807 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.63761792 |
| 4 | translational elongation (GO:0006414) | 6.15418859 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.12664475 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 6.01650732 |
| 7 | protein targeting to ER (GO:0045047) | 5.99404734 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.93595195 |
| 9 | DNA deamination (GO:0045006) | 5.77110432 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.68064132 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.63744422 |
| 12 | viral life cycle (GO:0019058) | 5.57678790 |
| 13 | cellular protein complex disassembly (GO:0043624) | 5.44798219 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.29015605 |
| 15 | translational initiation (GO:0006413) | 5.06126740 |
| 16 | protein complex disassembly (GO:0043241) | 4.89134150 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.81731465 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.81731465 |
| 19 | macromolecular complex disassembly (GO:0032984) | 4.53584652 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 4.50996621 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32449222 |
| 22 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.22615361 |
| 23 | protein targeting to membrane (GO:0006612) | 4.07060614 |
| 24 | ribosomal large subunit biogenesis (GO:0042273) | 3.97313387 |
| 25 | deoxyribose phosphate catabolic process (GO:0046386) | 3.85972472 |
| 26 | base-excision repair, AP site formation (GO:0006285) | 3.80391907 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.72422528 |
| 28 | translation (GO:0006412) | 3.63861972 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.63395763 |
| 30 | ncRNA 3-end processing (GO:0043628) | 3.62331327 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57126152 |
| 32 | negative regulation of B cell apoptotic process (GO:0002903) | 3.55896870 |
| 33 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.52854531 |
| 34 | pentose-phosphate shunt (GO:0006098) | 3.52384935 |
| 35 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.49517269 |
| 36 | heme biosynthetic process (GO:0006783) | 3.47967987 |
| 37 | chaperone-mediated protein transport (GO:0072321) | 3.37216847 |
| 38 | mRNA catabolic process (GO:0006402) | 3.35707241 |
| 39 | nucleotide salvage (GO:0043173) | 3.35164178 |
| 40 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.29452501 |
| 41 | mitochondrial calcium ion transport (GO:0006851) | 3.25601741 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.25070340 |
| 43 | positive regulation of prostaglandin secretion (GO:0032308) | 3.23491386 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.22776289 |
| 45 | protein complex biogenesis (GO:0070271) | 3.21379669 |
| 46 | UV protection (GO:0009650) | 3.20167173 |
| 47 | RNA catabolic process (GO:0006401) | 3.20071142 |
| 48 | purine nucleotide salvage (GO:0032261) | 3.18197925 |
| 49 | maternal placenta development (GO:0001893) | 3.17192012 |
| 50 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14155130 |
| 51 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.13149878 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.11619180 |
| 53 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.09324101 |
| 54 | GTP biosynthetic process (GO:0006183) | 3.08462742 |
| 55 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.06524396 |
| 56 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.05259473 |
| 57 | protein retention in ER lumen (GO:0006621) | 3.03896125 |
| 58 | regulation of mitochondrial translation (GO:0070129) | 3.03204433 |
| 59 | NADPH regeneration (GO:0006740) | 3.02737322 |
| 60 | deoxyribose phosphate metabolic process (GO:0019692) | 3.00806400 |
| 61 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95699652 |
| 62 | heme metabolic process (GO:0042168) | 2.92034611 |
| 63 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.89674653 |
| 64 | granulocyte differentiation (GO:0030851) | 2.88383913 |
| 65 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.87383119 |
| 66 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.87383119 |
| 67 | T cell apoptotic process (GO:0070231) | 2.87125920 |
| 68 | autophagic vacuole fusion (GO:0000046) | 2.86746474 |
| 69 | respiratory electron transport chain (GO:0022904) | 2.86031547 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.86029562 |
| 71 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.85027230 |
| 72 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83199504 |
| 73 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.81094705 |
| 74 | electron transport chain (GO:0022900) | 2.80343103 |
| 75 | galactose catabolic process (GO:0019388) | 2.79828489 |
| 76 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76715828 |
| 77 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76715828 |
| 78 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76715828 |
| 79 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.76626089 |
| 80 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.76476608 |
| 81 | establishment of protein localization to membrane (GO:0090150) | 2.75061735 |
| 82 | cytochrome complex assembly (GO:0017004) | 2.74707803 |
| 83 | protein targeting to mitochondrion (GO:0006626) | 2.74349720 |
| 84 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73102111 |
| 85 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.72752077 |
| 86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72641601 |
| 87 | response to interferon-beta (GO:0035456) | 2.72506820 |
| 88 | platelet formation (GO:0030220) | 2.72281724 |
| 89 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.72135758 |
| 90 | oxidative phosphorylation (GO:0006119) | 2.71906096 |
| 91 | UTP biosynthetic process (GO:0006228) | 2.70588914 |
| 92 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.69757684 |
| 93 | actin nucleation (GO:0045010) | 2.68061288 |
| 94 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.66707047 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.66616048 |
| 96 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.66224726 |
| 97 | viral protein processing (GO:0019082) | 2.66107918 |
| 98 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.66000540 |
| 99 | ATP synthesis coupled proton transport (GO:0015986) | 2.66000540 |
| 100 | establishment of protein localization to mitochondrion (GO:0072655) | 2.65474357 |
| 101 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.64543258 |
| 102 | lipoxygenase pathway (GO:0019372) | 2.62241767 |
| 103 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.61265893 |
| 104 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59930833 |
| 105 | GDP-mannose metabolic process (GO:0019673) | 2.59248343 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.58848235 |
| 107 | Peyers patch development (GO:0048541) | 2.58530845 |
| 108 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.58530845 |
| 109 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.58197024 |
| 110 | CTP biosynthetic process (GO:0006241) | 2.57952809 |
| 111 | CTP metabolic process (GO:0046036) | 2.57952809 |
| 112 | regulation of mitochondrial membrane potential (GO:0051881) | 2.57935983 |
| 113 | deoxyribonucleotide metabolic process (GO:0009262) | 2.57619287 |
| 114 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.56554592 |
| 115 | lymphocyte apoptotic process (GO:0070227) | 2.56347692 |
| 116 | regulation of erythrocyte differentiation (GO:0045646) | 2.55095052 |
| 117 | protein targeting (GO:0006605) | 2.54689271 |
| 118 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.54139288 |
| 119 | prostanoid biosynthetic process (GO:0046457) | 2.54043094 |
| 120 | prostaglandin biosynthetic process (GO:0001516) | 2.54043094 |
| 121 | mature B cell differentiation involved in immune response (GO:0002313) | 2.53338037 |
| 122 | pyrimidine nucleoside salvage (GO:0043097) | 2.52489263 |
| 123 | pyrimidine-containing compound salvage (GO:0008655) | 2.52489263 |
| 124 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51869801 |
| 125 | pentose metabolic process (GO:0019321) | 2.51730418 |
| 126 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51367827 |
| 127 | mannosylation (GO:0097502) | 2.51360486 |
| 128 | regulation of B cell apoptotic process (GO:0002902) | 2.50346506 |
| 129 | regulation of protein heterodimerization activity (GO:0043497) | 2.49838890 |
| 130 | metallo-sulfur cluster assembly (GO:0031163) | 2.48866703 |
| 131 | iron-sulfur cluster assembly (GO:0016226) | 2.48866703 |
| 132 | negative regulation of innate immune response (GO:0045824) | 2.48588673 |
| 133 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.47475683 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.47383741 |
| 135 | UTP metabolic process (GO:0046051) | 2.45645425 |
| 136 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.45611861 |
| 137 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.45611861 |
| 138 | nucleoside salvage (GO:0043174) | 2.45320587 |
| 139 | response to laminar fluid shear stress (GO:0034616) | 2.45268248 |
| 140 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.44110882 |
| 141 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.43607821 |
| 142 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.42304269 |
| 143 | tetrapyrrole biosynthetic process (GO:0033014) | 2.41172188 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.40915246 |
| 145 | regulation of prostaglandin secretion (GO:0032306) | 2.39970436 |
| 146 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.39556445 |
| 147 | aerobic respiration (GO:0009060) | 2.39480000 |
| 148 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.38767125 |
| 149 | positive regulation of antigen processing and presentation (GO:0002579) | 2.38573404 |
| 150 | regulation of respiratory burst (GO:0060263) | 2.38441957 |
| 151 | NIK/NF-kappaB signaling (GO:0038061) | 2.38426836 |
| 152 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37068639 |
| 153 | protein insertion into membrane (GO:0051205) | 2.37064471 |
| 154 | glucose catabolic process (GO:0006007) | 2.36876622 |
| 155 | positive regulation of TOR signaling (GO:0032008) | 2.36720283 |
| 156 | virion assembly (GO:0019068) | 2.36411659 |
| 157 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.36066463 |
| 158 | establishment of protein localization to organelle (GO:0072594) | 2.34295758 |
| 159 | porphyrin-containing compound metabolic process (GO:0006778) | 2.34063617 |
| 160 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.33743632 |
| 161 | positive regulation of histone deacetylation (GO:0031065) | 2.33386724 |
| 162 | barbed-end actin filament capping (GO:0051016) | 2.32002276 |
| 163 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.29090060 |
| 164 | cellular response to interferon-beta (GO:0035458) | 2.28945068 |
| 165 | regulation of metalloenzyme activity (GO:0048552) | 2.28818342 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27602216 |
| 167 | positive regulation of protein deacetylation (GO:0090312) | 2.25730121 |
| 168 | negative regulation of necroptotic process (GO:0060546) | 2.25526783 |
| 169 | sequestering of actin monomers (GO:0042989) | 2.25404368 |
| 170 | regulation of superoxide anion generation (GO:0032928) | 2.23995093 |
| 171 | regulation of necroptotic process (GO:0060544) | 2.22028933 |
| 172 | cellular component biogenesis (GO:0044085) | 2.21329643 |
| 173 | deoxyribonucleotide catabolic process (GO:0009264) | 2.20243844 |
| 174 | negative regulation of phagocytosis (GO:0050765) | 2.20083237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.74562902 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.79531251 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61634471 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.55659865 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43618558 |
| 6 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.38780121 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.31853704 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.18694136 |
| 9 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14292521 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.10878033 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93752577 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93099345 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92363278 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.91941818 |
| 15 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.87912568 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.86999585 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.86076187 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85549549 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.82513346 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79274304 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76561750 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76360929 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.76080202 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74980063 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73382919 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71210475 |
| 27 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.69760285 |
| 28 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.69428121 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69199708 |
| 30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.65025110 |
| 31 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.64653553 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64332397 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.61477935 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.59547438 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.58699806 |
| 36 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.58009081 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56966272 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56857739 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56677304 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53658029 |
| 41 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51585917 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.47454710 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47364147 |
| 44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44862423 |
| 45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44775404 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42873692 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42798494 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42006558 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41635769 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37676351 |
| 51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37619516 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37255198 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34761737 |
| 54 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34599342 |
| 55 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33461794 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33123059 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33045721 |
| 58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32239780 |
| 59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31546083 |
| 60 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31405694 |
| 61 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30683849 |
| 62 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.30357220 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30235615 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29550692 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29061791 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28607721 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.27868631 |
| 68 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27615557 |
| 69 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27552197 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27281549 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.27236576 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27005729 |
| 73 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.26757777 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25893371 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24959268 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24094923 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.23919624 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23827254 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23801066 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22652653 |
| 81 | P68_20966046_ChIP-Seq_HELA_Human | 1.22531909 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22357721 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22303605 |
| 84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22199619 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21616176 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21171329 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21098616 |
| 88 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20970860 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20646102 |
| 90 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20241668 |
| 91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19136382 |
| 92 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18681212 |
| 93 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.18192419 |
| 94 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.17969672 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17654249 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17492619 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17137961 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16621578 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16604347 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16543901 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16214698 |
| 102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15450323 |
| 103 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15327855 |
| 104 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15191446 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14653443 |
| 106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14085895 |
| 107 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13941503 |
| 108 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13493734 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13493490 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11296817 |
| 111 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11208074 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10916994 |
| 113 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10800997 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10614936 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10238148 |
| 116 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09034416 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08805966 |
| 118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08781529 |
| 119 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08775730 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08464018 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08145671 |
| 122 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08116602 |
| 123 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06658412 |
| 124 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06100103 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 1.06047074 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05829485 |
| 127 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05049389 |
| 128 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.04186001 |
| 129 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03843795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 2.72596415 |
| 2 | MP0003303_peritoneal_inflammation | 2.67251123 |
| 3 | MP0009840_abnormal_foam_cell | 2.62802366 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.59160797 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.49725193 |
| 6 | MP0003878_abnormal_ear_physiology | 2.41518220 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 2.41518220 |
| 8 | MP0003283_abnormal_digestive_organ | 2.33779730 |
| 9 | MP0003436_decreased_susceptibility_to | 2.27449229 |
| 10 | MP0000490_abnormal_crypts_of | 2.25450862 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.13543196 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.13543196 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.11796744 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.10950569 |
| 15 | MP0009785_altered_susceptibility_to | 2.08891096 |
| 16 | MP0001873_stomach_inflammation | 2.08128323 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.06096235 |
| 18 | MP0003866_abnormal_defecation | 2.04080352 |
| 19 | MP0002822_catalepsy | 1.98608486 |
| 20 | MP0005025_abnormal_response_to | 1.88698691 |
| 21 | MP0005451_abnormal_body_composition | 1.86160966 |
| 22 | MP0009278_abnormal_bone_marrow | 1.81406889 |
| 23 | MP0003075_altered_response_to | 1.79372680 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.77422885 |
| 25 | MP0005671_abnormal_response_to | 1.76024244 |
| 26 | MP0005387_immune_system_phenotype | 1.70409565 |
| 27 | MP0001790_abnormal_immune_system | 1.70409565 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.70267196 |
| 29 | MP0002398_abnormal_bone_marrow | 1.69181041 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.69047047 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.68385639 |
| 32 | MP0001800_abnormal_humoral_immune | 1.67955819 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.66953510 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.66182266 |
| 35 | MP0009764_decreased_sensitivity_to | 1.65940970 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.64668453 |
| 37 | MP0005360_urolithiasis | 1.63938625 |
| 38 | MP0002132_abnormal_respiratory_system | 1.63577855 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.62008581 |
| 40 | MP0002723_abnormal_immune_serum | 1.60765014 |
| 41 | MP0001819_abnormal_immune_cell | 1.59997806 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.58683058 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.57740035 |
| 44 | MP0005083_abnormal_biliary_tract | 1.56896502 |
| 45 | MP0001663_abnormal_digestive_system | 1.53489417 |
| 46 | MP0002722_abnormal_immune_system | 1.47901066 |
| 47 | MP0000716_abnormal_immune_system | 1.47749036 |
| 48 | MP0004858_abnormal_nervous_system | 1.47117170 |
| 49 | MP0008260_abnormal_autophagy | 1.46310720 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.45644410 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.45445621 |
| 52 | MP0002429_abnormal_blood_cell | 1.43891197 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.42594472 |
| 54 | MP0002405_respiratory_system_inflammati | 1.42132059 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.41775969 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.40946690 |
| 57 | MP0003186_abnormal_redox_activity | 1.40588822 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.38330494 |
| 59 | MP0004957_abnormal_blastocyst_morpholog | 1.37541731 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.36054134 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.36031909 |
| 62 | MP0005670_abnormal_white_adipose | 1.34952126 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.33947137 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.33147417 |
| 65 | MP0004947_skin_inflammation | 1.32205392 |
| 66 | MP0001905_abnormal_dopamine_level | 1.31454390 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.31369394 |
| 68 | MP0001764_abnormal_homeostasis | 1.30787237 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.30290201 |
| 70 | MP0002419_abnormal_innate_immunity | 1.30156259 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 1.28804026 |
| 72 | MP0000477_abnormal_intestine_morphology | 1.28666003 |
| 73 | MP0006082_CNS_inflammation | 1.28560728 |
| 74 | MP0000858_altered_metastatic_potential | 1.28503257 |
| 75 | MP0008469_abnormal_protein_level | 1.26841045 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.23530377 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.20937957 |
| 78 | MP0000604_amyloidosis | 1.20348372 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.19984272 |
| 80 | MP0003786_premature_aging | 1.18772329 |
| 81 | MP0003724_increased_susceptibility_to | 1.18285914 |
| 82 | MP0004510_myositis | 1.17666763 |
| 83 | MP0009379_abnormal_foot_pigmentation | 1.13246750 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 1.12750399 |
| 85 | MP0002006_tumorigenesis | 1.10828945 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 1.06909551 |
| 87 | MP0001853_heart_inflammation | 1.05033293 |
| 88 | MP0001533_abnormal_skeleton_physiology | 1.04296983 |
| 89 | MP0005310_abnormal_salivary_gland | 1.03046682 |
| 90 | MP0001542_abnormal_bone_strength | 1.00969485 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.98786499 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.98031151 |
| 93 | MP0005165_increased_susceptibility_to | 0.96028013 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95652076 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.93541916 |
| 96 | MP0000609_abnormal_liver_physiology | 0.92900764 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.91536415 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.91364446 |
| 99 | MP0009763_increased_sensitivity_to | 0.90916396 |
| 100 | MP0001881_abnormal_mammary_gland | 0.89986332 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.89888161 |
| 102 | MP0000598_abnormal_liver_morphology | 0.89229296 |
| 103 | MP0000343_altered_response_to | 0.89160068 |
| 104 | MP0005166_decreased_susceptibility_to | 0.88910422 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.87983977 |
| 106 | MP0000313_abnormal_cell_death | 0.87314673 |
| 107 | MP0002933_joint_inflammation | 0.86829453 |
| 108 | MP0003329_amyloid_beta_deposits | 0.86782760 |
| 109 | MP0003111_abnormal_nucleus_morphology | 0.86389662 |
| 110 | MP0003077_abnormal_cell_cycle | 0.86237529 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.83655586 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83620972 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.82892450 |
| 114 | MP0008995_early_reproductive_senescence | 0.82597665 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.80383276 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.78607475 |
| 117 | MP0005023_abnormal_wound_healing | 0.77101031 |
| 118 | MP0005390_skeleton_phenotype | 0.75248104 |
| 119 | MP0003011_delayed_dark_adaptation | 0.74705755 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.73743195 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.70682670 |
| 122 | MP0008873_increased_physiological_sensi | 0.70389932 |
| 123 | MP0000358_abnormal_cell_content/ | 0.69901217 |
| 124 | MP0008874_decreased_physiological_sensi | 0.69791664 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.68867543 |
| 126 | MP0001666_abnormal_nutrient_absorption | 0.68590468 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.68450403 |
| 128 | MP0005365_abnormal_bile_salt | 0.68392678 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.68187173 |
| 130 | MP0006054_spinal_hemorrhage | 0.67433313 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.63779159 |
| 132 | MP0004147_increased_porphyrin_level | 0.62746676 |
| 133 | MP0005330_cardiomyopathy | 0.62713816 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.62118202 |
| 135 | MP0001727_abnormal_embryo_implantation | 0.61144080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.65831797 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.39623558 |
| 3 | Reticulocytopenia (HP:0001896) | 4.69527155 |
| 4 | Petechiae (HP:0000967) | 4.23681209 |
| 5 | Pallor (HP:0000980) | 3.99049967 |
| 6 | Macrocytic anemia (HP:0001972) | 3.83593503 |
| 7 | Nasal polyposis (HP:0100582) | 3.51515241 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.46152455 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.46152455 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.46152455 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.42946187 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 3.36962538 |
| 13 | Thrombocytosis (HP:0001894) | 3.35177636 |
| 14 | Ragged-red muscle fibers (HP:0003200) | 3.13872217 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.11050335 |
| 16 | Increased CSF lactate (HP:0002490) | 3.10666806 |
| 17 | Chronic otitis media (HP:0000389) | 3.08234602 |
| 18 | Pustule (HP:0200039) | 3.03887531 |
| 19 | Obstructive lung disease (HP:0006536) | 3.02550522 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02550522 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.00463567 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.00463567 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 2.96575314 |
| 24 | Abnormality of reticulocytes (HP:0004312) | 2.96481549 |
| 25 | Prolonged neonatal jaundice (HP:0006579) | 2.89747161 |
| 26 | Inflammation of the large intestine (HP:0002037) | 2.79589989 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 2.78199764 |
| 28 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.77160807 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 2.76002296 |
| 30 | Hypertensive crisis (HP:0100735) | 2.74358326 |
| 31 | Polycythemia (HP:0001901) | 2.72777802 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.72593180 |
| 33 | Increased serum ferritin (HP:0003281) | 2.71534902 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.69558289 |
| 35 | Increased IgM level (HP:0003496) | 2.68803027 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66818475 |
| 37 | IgM deficiency (HP:0002850) | 2.66266998 |
| 38 | Microretrognathia (HP:0000308) | 2.64058602 |
| 39 | Colitis (HP:0002583) | 2.61792995 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.57818388 |
| 41 | Abnormal platelet function (HP:0011869) | 2.57472869 |
| 42 | Impaired platelet aggregation (HP:0003540) | 2.57472869 |
| 43 | Cerebral palsy (HP:0100021) | 2.55626945 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.54347678 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53570642 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.51793357 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.47501627 |
| 48 | Exercise intolerance (HP:0003546) | 2.47484987 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46970742 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.46854879 |
| 51 | Cerebral edema (HP:0002181) | 2.46092244 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.46062439 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.39817250 |
| 54 | 3-Methylglutaconic aciduria (HP:0003535) | 2.37923905 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.36936577 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36124284 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36124284 |
| 58 | Recurrent bronchitis (HP:0002837) | 2.35146816 |
| 59 | Increased serum lactate (HP:0002151) | 2.34796191 |
| 60 | Progressive neurologic deterioration (HP:0002344) | 2.34567076 |
| 61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.33659080 |
| 62 | Respiratory failure (HP:0002878) | 2.30647532 |
| 63 | Progressive microcephaly (HP:0000253) | 2.30396486 |
| 64 | Opisthotonus (HP:0002179) | 2.30150740 |
| 65 | Type I transferrin isoform profile (HP:0003642) | 2.29719274 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.29577010 |
| 67 | Emotional lability (HP:0000712) | 2.26412103 |
| 68 | Hepatic necrosis (HP:0002605) | 2.25869402 |
| 69 | Vacuolated lymphocytes (HP:0001922) | 2.24961713 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.24908011 |
| 71 | Rhabdomyolysis (HP:0003201) | 2.21940775 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19892937 |
| 73 | Mucopolysacchariduria (HP:0008155) | 2.19892937 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17449945 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 2.17449945 |
| 76 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.16958556 |
| 77 | Exertional dyspnea (HP:0002875) | 2.15159915 |
| 78 | Growth hormone excess (HP:0000845) | 2.13626431 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.12175454 |
| 80 | Vertebral compression fractures (HP:0002953) | 2.10197644 |
| 81 | Recurrent viral infections (HP:0004429) | 2.10180353 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.09720409 |
| 83 | Large eyes (HP:0001090) | 2.09356579 |
| 84 | Rough bone trabeculation (HP:0100670) | 2.09235667 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.08875547 |
| 86 | Acanthocytosis (HP:0001927) | 2.05976288 |
| 87 | Trismus (HP:0000211) | 2.04431042 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 2.02702320 |
| 89 | Abnormal glycosylation (HP:0012345) | 2.02702320 |
| 90 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02702320 |
| 91 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02702320 |
| 92 | Recurrent abscess formation (HP:0002722) | 2.00627033 |
| 93 | Urticaria (HP:0001025) | 2.00537833 |
| 94 | Mitochondrial inheritance (HP:0001427) | 2.00440862 |
| 95 | Dysostosis multiplex (HP:0000943) | 1.99462132 |
| 96 | Reticulocytosis (HP:0001923) | 1.99143395 |
| 97 | Epistaxis (HP:0000421) | 1.98694610 |
| 98 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98537916 |
| 99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98537916 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98537916 |
| 101 | Poikiloderma (HP:0001029) | 1.97512842 |
| 102 | Granulocytopenia (HP:0001913) | 1.94396167 |
| 103 | Aplastic anemia (HP:0001915) | 1.94312171 |
| 104 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93747258 |
| 105 | Cellulitis (HP:0100658) | 1.93488829 |
| 106 | Abnormality of T cells (HP:0002843) | 1.92952799 |
| 107 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.91754530 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90552164 |
| 109 | Muscle fiber atrophy (HP:0100295) | 1.90275365 |
| 110 | Recurrent skin infections (HP:0001581) | 1.89949144 |
| 111 | Abnormal hemoglobin (HP:0011902) | 1.89705864 |
| 112 | Increased serum pyruvate (HP:0003542) | 1.88094874 |
| 113 | Pancytopenia (HP:0001876) | 1.87641939 |
| 114 | Amyloidosis (HP:0011034) | 1.86927773 |
| 115 | Protrusio acetabuli (HP:0003179) | 1.86590747 |
| 116 | Microcytic anemia (HP:0001935) | 1.85310372 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 1.84650282 |
| 118 | Loss of speech (HP:0002371) | 1.84526027 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 1.84487631 |
| 120 | Poikilocytosis (HP:0004447) | 1.83164580 |
| 121 | Abnormality of B cell number (HP:0010975) | 1.82888002 |
| 122 | Myopathic facies (HP:0002058) | 1.81870243 |
| 123 | Villous atrophy (HP:0011473) | 1.80695447 |
| 124 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80695447 |
| 125 | Abnormality of macrophages (HP:0004311) | 1.80284126 |
| 126 | Lipid accumulation in hepatocytes (HP:0006561) | 1.78982877 |
| 127 | Failure to thrive in infancy (HP:0001531) | 1.78357515 |
| 128 | Acute necrotizing encephalopathy (HP:0006965) | 1.78290890 |
| 129 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78264066 |
| 130 | Abnormal cartilage morphology (HP:0002763) | 1.77966220 |
| 131 | Reduced antithrombin III activity (HP:0001976) | 1.77352255 |
| 132 | Myositis (HP:0100614) | 1.76331705 |
| 133 | Papilloma (HP:0012740) | 1.76250252 |
| 134 | Verrucae (HP:0200043) | 1.76250252 |
| 135 | Progressive muscle weakness (HP:0003323) | 1.75811108 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 1.75482570 |
| 137 | Acute encephalopathy (HP:0006846) | 1.74110038 |
| 138 | Agammaglobulinemia (HP:0004432) | 1.73761573 |
| 139 | Hyperphosphaturia (HP:0003109) | 1.72870567 |
| 140 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.72075146 |
| 141 | Stomatitis (HP:0010280) | 1.71809975 |
| 142 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71641743 |
| 143 | Late onset (HP:0003584) | 1.71332440 |
| 144 | Purpura (HP:0000979) | 1.70657538 |
| 145 | Cholecystitis (HP:0001082) | 1.70416341 |
| 146 | Abnormal gallbladder physiology (HP:0012438) | 1.70416341 |
| 147 | Increased density of long bones (HP:0006392) | 1.69632763 |
| 148 | Generalized aminoaciduria (HP:0002909) | 1.69189950 |
| 149 | Meningitis (HP:0001287) | 1.68776490 |
| 150 | Flat acetabular roof (HP:0003180) | 1.67203710 |
| 151 | Lactic acidosis (HP:0003128) | 1.63401862 |
| 152 | Cheilitis (HP:0100825) | 1.61714454 |
| 153 | Increased hepatocellular lipid droplets (HP:0006565) | 1.61199959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.89546282 |
| 2 | ERN1 | 3.84878321 |
| 3 | NME2 | 3.70155196 |
| 4 | MAP3K10 | 3.39037790 |
| 5 | MAP4K1 | 3.20153058 |
| 6 | TRIB3 | 2.84892011 |
| 7 | TLK1 | 2.78454289 |
| 8 | EEF2K | 2.75090666 |
| 9 | TESK2 | 2.40520507 |
| 10 | BCKDK | 2.17095621 |
| 11 | TBK1 | 2.15122190 |
| 12 | PIM2 | 2.14489627 |
| 13 | PKN2 | 2.08616484 |
| 14 | BUB1 | 2.00099870 |
| 15 | MAP2K2 | 1.90391127 |
| 16 | KDR | 1.88671845 |
| 17 | MAP3K11 | 1.88351518 |
| 18 | LRRK2 | 1.87408571 |
| 19 | LIMK1 | 1.84089583 |
| 20 | DYRK3 | 1.74523172 |
| 21 | TESK1 | 1.73752548 |
| 22 | BLK | 1.66548507 |
| 23 | CDK19 | 1.64751544 |
| 24 | TXK | 1.59657222 |
| 25 | TAOK2 | 1.55023197 |
| 26 | GRK6 | 1.50696684 |
| 27 | ILK | 1.48155390 |
| 28 | SCYL2 | 1.46465633 |
| 29 | ZAP70 | 1.45925288 |
| 30 | MST1R | 1.41859977 |
| 31 | TYK2 | 1.41401535 |
| 32 | SMG1 | 1.39419413 |
| 33 | DAPK3 | 1.36695955 |
| 34 | KIT | 1.34341829 |
| 35 | IKBKE | 1.28713274 |
| 36 | BTK | 1.27757758 |
| 37 | TEC | 1.27070406 |
| 38 | RPS6KA4 | 1.26833147 |
| 39 | MAP3K7 | 1.26090679 |
| 40 | MAP4K2 | 1.23291429 |
| 41 | NEK2 | 1.22983183 |
| 42 | DAPK1 | 1.22834717 |
| 43 | PAK4 | 1.22729316 |
| 44 | VRK1 | 1.20613356 |
| 45 | TAOK1 | 1.19690524 |
| 46 | FLT3 | 1.11852534 |
| 47 | DYRK1B | 1.09175443 |
| 48 | FGFR4 | 1.06997775 |
| 49 | RPS6KB2 | 1.05645911 |
| 50 | STK16 | 1.02646864 |
| 51 | SIK1 | 1.01468480 |
| 52 | TAOK3 | 1.01278027 |
| 53 | MAP2K7 | 0.96047332 |
| 54 | IKBKB | 0.92793174 |
| 55 | CSNK1G3 | 0.91422624 |
| 56 | TNK2 | 0.90145146 |
| 57 | MAP3K8 | 0.89063892 |
| 58 | CSF1R | 0.84468592 |
| 59 | JAK3 | 0.78619748 |
| 60 | MAPKAPK3 | 0.78529522 |
| 61 | SYK | 0.78415700 |
| 62 | PIK3CA | 0.77526332 |
| 63 | BRAF | 0.75692390 |
| 64 | PIM1 | 0.75018007 |
| 65 | IRAK4 | 0.74747023 |
| 66 | ICK | 0.74570144 |
| 67 | STK10 | 0.73724496 |
| 68 | IRAK3 | 0.73695668 |
| 69 | MAPK11 | 0.73675545 |
| 70 | CDK4 | 0.72970358 |
| 71 | EPHB2 | 0.72350111 |
| 72 | PTK6 | 0.68816455 |
| 73 | FES | 0.67572306 |
| 74 | PRKG2 | 0.67462553 |
| 75 | CSK | 0.66581628 |
| 76 | RAF1 | 0.65216922 |
| 77 | ZAK | 0.64985077 |
| 78 | ABL2 | 0.64761714 |
| 79 | PASK | 0.64426296 |
| 80 | DYRK2 | 0.62463923 |
| 81 | BMX | 0.61272383 |
| 82 | ARAF | 0.59934036 |
| 83 | PAK1 | 0.58192709 |
| 84 | CSNK1A1L | 0.57366954 |
| 85 | EIF2AK1 | 0.56427091 |
| 86 | GRK5 | 0.54954858 |
| 87 | PRPF4B | 0.53749132 |
| 88 | MAP3K1 | 0.53670112 |
| 89 | LYN | 0.53326090 |
| 90 | PRKD2 | 0.53275142 |
| 91 | TGFBR2 | 0.52431537 |
| 92 | MAP3K3 | 0.50869283 |
| 93 | MAP2K3 | 0.49495345 |
| 94 | GRK7 | 0.49487929 |
| 95 | MATK | 0.49063729 |
| 96 | EPHB1 | 0.48487833 |
| 97 | CHUK | 0.47331082 |
| 98 | MAPK4 | 0.47150117 |
| 99 | EPHA2 | 0.46328175 |
| 100 | RPS6KA1 | 0.46087474 |
| 101 | MUSK | 0.45189232 |
| 102 | CSNK1G2 | 0.44818550 |
| 103 | RPS6KA2 | 0.44747188 |
| 104 | HCK | 0.44653393 |
| 105 | JAK2 | 0.42487091 |
| 106 | MAP3K5 | 0.42048893 |
| 107 | AURKB | 0.41813875 |
| 108 | DMPK | 0.41172650 |
| 109 | PRKD3 | 0.40582934 |
| 110 | WEE1 | 0.40487005 |
| 111 | LCK | 0.40073201 |
| 112 | PAK2 | 0.38435972 |
| 113 | CAMK2G | 0.38032428 |
| 114 | MYLK | 0.37661375 |
| 115 | PRKCI | 0.37013005 |
| 116 | CSNK1G1 | 0.36624609 |
| 117 | TGFBR1 | 0.36469869 |
| 118 | RPS6KA6 | 0.35456971 |
| 119 | MST4 | 0.35306234 |
| 120 | CAMKK2 | 0.33837685 |
| 121 | CDK7 | 0.32950330 |
| 122 | SIK3 | 0.32949294 |
| 123 | HIPK2 | 0.32109729 |
| 124 | CCNB1 | 0.31966906 |
| 125 | MAP3K12 | 0.31360003 |
| 126 | MAPKAPK5 | 0.31168076 |
| 127 | PRKD1 | 0.30594109 |
| 128 | RPS6KC1 | 0.29831513 |
| 129 | RPS6KL1 | 0.29831513 |
| 130 | AKT2 | 0.29798973 |
| 131 | TIE1 | 0.29793801 |
| 132 | MAPKAPK2 | 0.29469273 |
| 133 | ITK | 0.29383210 |
| 134 | AURKA | 0.29239782 |
| 135 | PRKCD | 0.29184587 |
| 136 | RPS6KA5 | 0.29180021 |
| 137 | CDK14 | 0.28139939 |
| 138 | CSNK2A1 | 0.28029906 |
| 139 | SIK2 | 0.27960486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.88701960 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 4.32065342 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.33611628 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.26511763 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03865312 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.03534018 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.98264480 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 1.95907724 |
| 9 | Asthma_Homo sapiens_hsa05310 | 1.92541223 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90006581 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.86662658 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84656408 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81276689 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79597522 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76019213 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75297762 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.68620495 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.68007282 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58415016 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56292744 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.56009184 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.54291009 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51330272 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.47242829 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43219166 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41364887 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41299638 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36437449 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36437433 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34469562 |
| 31 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.31538305 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.29137659 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.26211470 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25752760 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25365714 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24857137 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22266852 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21296363 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17989626 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.17324027 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14826105 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08616042 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06209684 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05284608 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04533259 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04298783 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.02968762 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02861559 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02671607 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01518788 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99528493 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98785599 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98213800 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97325853 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96555566 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.95388895 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95189582 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92387705 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89362070 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88284979 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86801009 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85795061 |
| 63 | Homologous recombination_Homo sapiens_hsa03440 | 0.84375737 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83568298 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.83382112 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83152728 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.82192593 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80911549 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80329951 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79584803 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.78723225 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76713276 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75070912 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74907103 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73989686 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.73187763 |
| 77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72924381 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.72768680 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.72565350 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72277463 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71450790 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70490337 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70152293 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69442753 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.69069534 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68412977 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67081393 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66031569 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65070313 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64278851 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63886147 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61629099 |
| 93 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60385183 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59356388 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59151246 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58755529 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58633590 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58462564 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58424242 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58229762 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58225278 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55971979 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55715156 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55332963 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55236810 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55059682 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.53651549 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52706589 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51137568 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.47829444 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46098354 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45213505 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44749717 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.44068967 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43956870 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43711151 |
| 117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43593365 |
| 118 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43579136 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.43478081 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43465300 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.43180946 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.43070099 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42998677 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.42964597 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42059689 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40554239 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40004598 |
| 128 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39369797 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.38420664 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36299883 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36118318 |
| 132 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.29755194 |

